Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SERPINB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IDO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFC2-KCTD14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101928196 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASB17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927382 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CC2D2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PADI4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01312 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LHCGR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MUCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PITPNM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WT1-AS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on